Lifeward Q2 FY26 net loss widens to $11.52 million; revenue rises 16% to $6.6 million
LFWD•Quarterly results
- Lifeward posted Q2 2026 revenue up 16% to $6.6 million, marking its strongest quarterly level since Q4 2024.
- GAAP operating loss narrowed 37% to $4.2 million, while GAAP net loss widened to $11.5 million, or $4.12 a share.
- Gross margin slipped 3 percentage points to 41% on higher tariffs, FX swings, and a 4% revenue-sharing expense tied to Oramed.
- Cash and cash equivalents rose to $9.4 million as of June 30, 2026; pro forma cash was about $11 million.
Operational update
- Lifeward launched a pilot with Ottobock Care; CEO Mark Grant said revenue momentum should continue in the second half of 2026.
